Aptamer Sciences Revenue vs. Total Debt
| 291650 Stock | KRW 1,816 73.00 3.86% |
For Aptamer Sciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Aptamer Sciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Aptamer Sciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Aptamer Sciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Aptamer Sciences over time as well as its relative position and ranking within its peers.
Aptamer |
Aptamer Sciences Total Debt vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Aptamer Sciences's current stock value. Our valuation model uses many indicators to compare Aptamer Sciences value to that of its competitors to determine the firm's financial worth. Aptamer Sciences is rated below average in revenue category among its peers. It also is rated below average in total debt category among its peers making up about 0.25 of Total Debt per Revenue. The ratio of Revenue to Total Debt for Aptamer Sciences is roughly 3.92 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Aptamer Sciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aptamer Sciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Aptamer Total Debt vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Aptamer Sciences |
| = | 269.28 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Aptamer Sciences |
| = | 68.63 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Aptamer Sciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Aptamer Sciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Aptamer Sciences will eventually generate negative long term returns. The profitability progress is the general direction of Aptamer Sciences' change in net profit over the period of time. It can combine multiple indicators of Aptamer Sciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Aptamer Sciences, Inc., a bio venture company, focuses on the Aptamer technology platform for the development of therapeutic and diagnostic platforms. Aptamer Sciences, Inc. was founded in 2011 and is headquartered in Seongnam, South Korea. Aptamer Sciences is traded on Korean Securities Dealers Automated Quotations in South Korea.
Aptamer Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Aptamer Sciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Aptamer Sciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Aptamer Sciences' important profitability drivers and their relationship over time.
Use Aptamer Sciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptamer Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptamer Sciences will appreciate offsetting losses from the drop in the long position's value.Aptamer Sciences Pair Trading
Aptamer Sciences Pair Trading Analysis
The ability to find closely correlated positions to Aptamer Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptamer Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptamer Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptamer Sciences to buy it.
The correlation of Aptamer Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptamer Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptamer Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptamer Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Aptamer Sciences position
In addition to having Aptamer Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Emerging Markets ETFs Thematic Idea Now
Emerging Markets ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Emerging Markets ETFs theme has 29 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Emerging Markets ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Aptamer Stock
To fully project Aptamer Sciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Aptamer Sciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Aptamer Sciences' income statement, its balance sheet, and the statement of cash flows.